Enoxaparin is used in the treatment and prevention of Blood clots. It prevents the formation of blood clots and is used to treat conditions such as deep vein thrombosis and pulmonary embolism.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Intravas 80mg Injection is a type of medication known as a blood thinner or anticoagulant. It is used to treat and prevent harmful blood clots in various medical conditions, such as unstable angina, after surgery or extended bed rest, following a heart attack, and to prevent blood clot formation in dialysis machine tubes.
The active ingredient in Intravas 80mg Injection is Enoxaparin, which is a low molecular weight heparin. It works by stopping existing blood clots from getting larger, allowing the body to break them down and prevent them from causing harm. Additionally, it helps prevent the formation of new blood clots in the bloodstream.
It's essential to have Intravas 80mg Injection 0.8 ml administered by a healthcare professional and not attempt to self-administer. Some possible side effects may include bleeding, increased liver enzymes, skin rash, itching, bruising, pain at the injection site, and headaches. These side effects are generally temporary and do not usually require medical attention. However, if they persist, it's essential to inform your doctor promptly.
Before receiving Intravas 80mg Injection 0.8 ml, inform your doctor if you have any allergies to this medication or any other drugs. If you are pregnant or breastfeeding, it's crucial to discuss this with your doctor beforehand. Inform your doctor about any pre-existing medical conditions you may have, such as stomach ulcers, recent brain, eye, or spine surgery, recent bleeding stroke, diabetes, high blood pressure, recent stroke, kidney or liver disorders, and if you have high levels of potassium in your blood. Your doctor will take these factors into consideration to ensure the safe use of the medication.
Avoid consumption of alcohol before receiving Intravas 80mg Injection.
Intravas 80mg Injection is not recommended for use in pregnancy. Your doctor will weigh the benefits and risks before prescribing this medicine to you.
Intravas 80mg Injection is not recommended for use in breastfeeding. Your doctor will weigh the benefits and risks before prescribing this medicine to you.
Intravas 80mg Injection does not affect your ability to drive or operate machinery. However, do not drive or handle any heavy tools or machines if your ability is affected by Intravas 40mg Injection.
Intravas 80mg Injection may increase the risk of bleeding if you have kidney problems. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Intravas 80mg Injection is known to increase the levels of liver enzymes causing serious complications. Therefore, it should be used with caution if you have liver problems.
Intravas 80mg Injection is an anticoagulant medicine. It inactivates certain proteins (such as coagulation factor II a and X a) in the blood that causes blood clotting. This reduces the chances of blood clot formation within the body which therefore prevents blockage of blood vessels.
Intravas 80mg Injection is prescribed to address various medical conditions related to blood clotting, including:
In all these scenarios, Intravas 80mg Injection, containing Enoxaparin, a low molecular weight heparin, is employed as an anticoagulant or blood thinner to reduce the risk of harmful blood clots, thereby safeguarding patients from potentially serious consequences like stroke, organ damage, or even death. It is crucial to have this medication administered under the supervision of a healthcare professional. Additionally, patients are advised to inform their doctor about any allergies or pre-existing medical conditions before receiving this medication.
Enoxaparin is a low molecular weight heparin (LMWH) with anticoagulant properties. It works by enhancing the inhibition of activated clotting factors, particularly thrombin and factor Xa, through its interaction with antithrombin III. Antithrombin III is a natural anticoagulant in the body that inhibits the activity of various clotting factors. Enoxaparin helps antithrombin III in its role, leading to a reduction in blood clot formation.
By targeting specific clotting factors, Enoxaparin is effective in preventing the growth of existing blood clots and reducing the formation of new ones, thereby reducing the risk of complications associated with blood clots, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and other clot-related conditions.
Enoxaparin Sodium is used in the treatment and prevention of various conditions related to blood clotting. The dosing and administration of Enoxaparin vary depending on the specific medical condition being treated. Here are some key points to note regarding its use:
It's essential to follow the dosing instructions provided by your doctor or healthcare professional. Enoxaparin is usually administered subcutaneously, and it should not be self-injected. It is typically given in a hospital setting, and patients should not attempt to administer it on their own. Proper care and monitoring for signs of bleeding are essential during Enoxaparin therapy.
If you have any concerns or questions about the treatment, dosing, or administration, it's crucial to discuss them with your healthcare provider to ensure the safe and effective use of the medication.
Before receiving Intravas 80mg Injection, it is crucial to inform your doctor about any other medications you are taking to avoid potential interactions or complications. Some medications may interact with Intravas 80mg Injection and affect its effectiveness or increase the risk of bleeding. Here are some specific medications to mention to your doctor:
The use of enoxaparin during pregnancy should be approached with caution and only under the close supervision of a healthcare professional. Human data from a retrospective cohort study suggest that enoxaparin does not increase the risk of major developmental abnormalities. However, it's important to note that pregnancy itself confers an increased risk of thromboembolism, which may be higher for women with pre-existing thromboembolic disease and certain high-risk pregnancy conditions.
Pregnant women with mechanical prosthetic heart valves may be at even higher risk for thrombosis. Those with thromboembolic disease or inherited/acquired thrombophilias are also at an increased risk of other maternal complications and fetal loss, regardless of the type of anticoagulant used.
All patients, including pregnant women, receiving anticoagulants are at risk of bleeding, and pregnant women on enoxaparin should be closely monitored for any signs of bleeding or excessive anticoagulation. Hemorrhage can occur at any site and may have serious consequences for both the mother and the fetus.
The potential hazards to the fetus and mother should be considered if enoxaparin therapy is administered during pregnancy. The decision to use enoxaparin in pregnant women should be carefully weighed against the potential benefits and risks, and the patient should be informed of the potential risks to both the mother and the fetus.
Regarding lactation, it is not known whether enoxaparin is excreted into human milk. In lactating rats, the passage of enoxaparin or its metabolites into milk is very limited. However, there is no information available on the effect of enoxaparin on breastfed infants or on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for enoxaparin therapy and any potential adverse effects on the breastfed child from the drug or the underlying maternal condition.
As there is uncertainty and limited data regarding the safety of enoxaparin during pregnancy and lactation, it is generally not recommended to use this medication in these situations unless the potential benefits outweigh the potential risks and other treatment options are not suitable. Pregnant or lactating women should discuss their individual circumstances with their healthcare provider to determine the most appropriate treatment plan.
It is essential for patients to inform their doctors if they are on active treatment with Intravas 80mg Injection before any surgery is scheduled. This is crucial because Intravas 80mg Injection is an anticoagulant, and its use may need to be adjusted or temporarily stopped before certain surgical procedures to minimize bleeding risks.
Moreover, the doctor should be informed if the patient is underweight or overweight, as these factors can influence the dosage and response to the medication.
Overall, open communication with the doctor about medical history and any ongoing treatments is crucial for ensuring the safe and effective use of Intravas 80mg Injection and minimizing potential risks or complications.
Store below 25°C
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.